Is Fulcrum Therapeutics, Inc. (FULC) a Buy, Sell, or Hold?
NASDAQ : FULC
Fulcrum Therapeutics, Inc.
$3.65 USD
$0.15 (4.29%)
- Volume
- 2.3M
- Average Volume
- 2.44M
- Market Capitalization
- $197.51M
- P/E Ratio
- -3.17
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $15.74
- Year Low
- $2.83
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $34.33
Analyst Consensus Summary
Consensus Rating
Sell
17 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-8.8%
vs Current Price
Price Target
$4.00
Average TargetPrice Target Range
Lowest Target
$3.00
21.7% UPSIDE
Average Target
$4.00
Median Estimate
Highest Target
$4.00
-8.8% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 17
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 7 | 7 | 3 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Andrew Fein | $3 | $6.42 | 2026-06-02 06:06 AM | -53.3% |
| Truist Financial | Gregory Renza | $4 | $6.42 | 2026-06-02 01:04 AM | -37.7% |
| Truist Financial | Gregory Renza | $17 | $8.955 | 2026-02-24 01:38 PM | 89.8% |
| Cantor Fitzgerald | Kristen Kluska | $24 | $13.74 | 2025-12-08 08:42 AM | 74.7% |